Press Releases

July 24, 2012 Record Sales & Profits Net Sales up 44%, PBT up 67%, PAT up 33% Quarter I Results, FY 2012-13

July 6, 2012 Ernst & Young announces Lupin Pharmaceuticals Inc., CEO Vinita Gupta as Entrepreneur of the Year, Maryland – 060712

June 5, 2012 Lupin receives FDA approval for SUPRAX® (Cefixime) Capsules, 400 mg NDA Approval to add to growing SUPRAX® Franchise ®

May 15, 2012 Lupin Launches Generic Combivir® Tablets

May 10, 2012 Lupin Sales and Operating Profit up 22%

April 24, 2012 Lupin To Set Up New Formulations Manufacturing Facility In MIHAN

April 19, 2012 Lupin Resumes Sales of Generic Fortamet®

March 28, 2012 Lupin launchesGeneric SEROQUEL® Tablets Receives final FDA Approval for its Generic SEROQUEL® Tablets

March 3, 2012 Lupin launchesGeneric Geodon® Capsules Receives final FDA Approval for its Generic Geodon® Capsules